|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,056 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,131,096 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
786,589 |
|
|
Total
Value |
$65,069,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
850 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 34
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-06-06 |
4 |
S |
$27.39 |
$54,772 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
132,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-07-14 |
4 |
AS |
$30.00 |
$30,000 |
D/D |
(1,000) |
131,093 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2011-07-26 |
4 |
A |
$1.65 |
$19,185 |
D/D |
11,627 |
21,748 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-02 |
4 |
S |
$30.23 |
$242,136 |
D/D |
(8,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-02 |
4 |
OE |
$6.46 |
$25,840 |
D/D |
4,000 |
135,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-12 |
4 |
OE |
$6.46 |
$19,380 |
D/D |
3,000 |
130,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-12 |
4 |
S |
$27.10 |
$81,288 |
D/D |
(3,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-19 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-19 |
4 |
S |
$26.75 |
$53,496 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-30 |
4 |
S |
$29.01 |
$58,018 |
D/D |
(2,000) |
127,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-08-30 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-09-28 |
4 |
AS |
$32.00 |
$32,000 |
D/D |
(1,000) |
126,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-02-23 |
4 |
S |
$35.31 |
$176,541 |
D/D |
(5,000) |
121,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-02-29 |
4 |
S |
$36.26 |
$36,258 |
D/D |
(1,000) |
115,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-08 |
4 |
S |
$35.00 |
$35,000 |
D/D |
(1,000) |
114,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-09 |
4 |
S |
$34.46 |
$516,867 |
D/D |
(15,000) |
114,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-03-09 |
4 |
OE |
$6.47 |
$97,050 |
D/D |
15,000 |
129,093 |
0 |
- |
|
ITMN |
InterMune Inc |
Director |
|
2012-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,225 |
4,225 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-04-27 |
4 |
AS |
$34.66 |
$769,872 |
D/D |
(22,000) |
112,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-04-27 |
4 |
OE |
$9.86 |
$197,200 |
D/D |
20,000 |
134,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-04-30 |
4 |
A |
$19.35 |
$21,242 |
D/D |
1,098 |
113,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-01 |
4 |
OE |
$9.86 |
$197,200 |
D/D |
20,000 |
133,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-01 |
4 |
AS |
$35.00 |
$699,920 |
D/D |
(20,000) |
113,191 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2012-05-02 |
4 |
AS |
$35.72 |
$357,200 |
D/D |
(10,000) |
113,191 |
0 |
- |
|
850 Records found
|
|
Page 7 of 34 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|